Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma

References

• Robinson D, Humbert M, Buhl R, et al. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017;47:161–175.
   PubMed Web of Science ®Google Scholar
• Global strategy for asthma management and prevention 2018; 2018. Available from: https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-V1.3-002.pdf. Accessed September 15, 2021.
   Google Scholar
• Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59:469–478. doi:10.1111/j.1398-9995.2004.00526.x
   PubMed Web of Science ®Google Scholar
• Gandhi NA, Bennett BL, Graham NM, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15:35–50. doi:10.1038/nrd4624
   PubMed Web of Science ®Google Scholar
• Corren J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol. 1997;99:S781–6. doi:10.1016/S0091-6749(97)70127-1
   PubMed Web of Science ®Google Scholar
• Seys SF, Scheers H, Van den Brande P, et al. Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients. Respir Res. 2017;18:39. doi:10.1186/s12931-017-0524-y
   PubMed Web of Science ®Google Scholar
• Peters MC, Mekonnen ZK, Yuan S, Bhakta NR, Woodruff PG, Fahy JV. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol. 2014;133:388–394. doi:10.1016/j.jaci.2013.07.036
   PubMed Web of Science ®Google Scholar
• Diamont Z. Type 2 inflammation and the evolving profile of uncontrolled persistent asthma. 28th European Respiratory Society (ERS), International Congress in Paris: France; 2018. Available from: https://emj.emg-health.com/wp-content/uploads/sites/2/2018/12/Type-2-Inflammation-and-the-Evolving….pdf. Accessed September 15, 2021.
   Google Scholar
• Global strategy for asthma management and prevention (update); 2019. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf. Accessed September 15, 2021.
   Google Scholar
• Gershon AS, Wang C, Guan J, To T. Burden of comorbidity in individuals with asthma. Thorax. 2010;65:612–618. doi:10.1136/thx.2009.131078
   PubMed Web of Science ®Google Scholar
• Chanoine S, Sanchez M, Pin I, et al. Multimorbidity medications and poor asthma prognosis. Eur Respir J. 2018;51(4):1702114. doi:10.1183/13993003.02114-2017
   Web of Science ®Google Scholar
• Jantunen J, Haahtela T, Salimäki J, et al. Multimorbidity in asthma, allergic conditions and COPD increase disease severity, drug use and costs: the Finnish Pharmacy Survey. Int Arch Allergy Immunol. 2019;179:273–280. doi:10.1159/000498861
   Web of Science ®Google Scholar
• Cazzoletti L, Marcon A, Corsico A, et al. Asthma severity according to Global Initiative for Asthma and its determinants: an international study. Int Arch Allergy Immunol. 2010;151:70–79. doi:10.1159/000232572
   PubMed Web of Science ®Google Scholar
• Chipps BE, Haselkorn T, Paknis B, et al. More than a decade follow-up in patients with severe or difficult-to-treat asthma: the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II. J Allergy Clin Immunol. 2018;141:1590–7 e9. doi:10.1016/j.jaci.2017.07.014
   PubMed Web of Science ®Google Scholar
• Matsusaka M, Kabata H, Fukunaga K, et al. Phenotype of asthma related with high serum periostin levels. Allergol Int. 2015;64:175–180. doi:10.1016/j.alit.2014.07.003
   PubMed Web of Science ®Google Scholar
• Schleich F, Brusselle G, Louis R, et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). Respir Med. 2014;108:1723–1732. doi:10.1016/j.rmed.2014.10.007
   PubMed Web of Science ®Google Scholar
• Giavina-Bianchi P, Aun MV, Takejima P, Kalil J, Agondi RC. United airway disease: current perspectives. J Asthma Allergy. 2016;9:93–100. doi:10.2147/JAA.S81541
   PubMed Web of Science ®Google Scholar
• Blöndal V, Malinovschi A, Sundbom F, et al. Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GA(2) LEN study. Clin Exp Allergy. 2021;51:262–272. doi:10.1111/cea.13759
   PubMed Web of Science ®Google Scholar
• Oka A, Hirano T, Yamaji Y, et al. Determinants of incomplete asthma control in patients with allergic rhinitis and asthma. J Allergy Clin Immunol Pract. 2017;5:160–164. doi:10.1016/j.jaip.2016.08.002
   PubMed Web of Science ®Google Scholar
• OPCRD: an Introduction; 2017. Available from: http://opcrd.co.uk/wp-content/uploads/2017/11/opcrd-brochure-final-21.11.17.pdf. Accessed September 15, 2021.
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Colice G, Chisholm A, Dima AL, et al. Performance of database-derived severe exacerbations and asthma control measures in asthma: responsiveness and predictive utility in a UK primary care database with linked questionnaire data. Pragmat Obs Res. 2018;9:29–42. doi:10.2147/POR.S151615
   PubMed Web of Science ®Google Scholar
• Noble M, Burden A, Stirling S. et al. Predicting asthma-related crisis events using routine electronic healthcare data. Br J Gen Pract. 2021. BJGP.2020.1042. doi:10.3399/BJGP.2020.1042
   Web of Science ®Google Scholar
• Tran TN, Kerkhof M, Carter V, Price DB. Persistence of eosinophilic asthma endotype and clinical outcomes: a real-world observational study. J Asthma Allergy. 2021;14:727–742. doi:10.2147/JAA.S306416
   Web of Science ®Google Scholar
• Ryan D, Heatley H, Heaney LG, et al. Potential severe asthma hidden in UK primary care. J Allergy Clin Immunol Pract. 2021;9:1612–23 e9. doi:10.1016/j.jaip.2020.11.053
   PubMed Web of Science ®Google Scholar
• Fahy JV. Type 2 inflammation in asthma — present in most, absent in many. Nat Rev Immunol. 2015;15:57–65. doi:10.1038/nri3786
   PubMed Web of Science ®Google Scholar
• Chen L, Grabowski KA, Xin JP, et al. IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils. J Immunol. 2004;172:2059–2066. doi:10.4049/jimmunol.172.4.2059
   PubMed Web of Science ®Google Scholar
• Furuta GT, Aceves SS. The national biome initiative: an allergy perspective. J Allergy Clin Immunol. 2017;139:1131–1134. doi:10.1016/j.jaci.2017.02.008
   Web of Science ®Google Scholar
• Peters S. The impact of comorbid atopic disease on asthma: clinical expression and treatment. J Asthma. 2007;44:149–161. doi:10.1080/02770900600925478
   PubMed Web of Science ®Google Scholar
• Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy. 2005;35:282–287. doi:10.1111/j.1365-2222.2005.02182.x
   PubMed Web of Science ®Google Scholar
• Schatz M, Zeiger RS, Chen W, Yang SJ, Corrao MA, Quinn VP. The burden of rhinitis in a managed care organization. Ann Allergy Asthma Immunol. 2008;101:240–247. doi:10.1016/S1081-1206(10)60488-7
   PubMed Web of Science ®Google Scholar
• Vandenplas O, Dramaix M, Joos G, et al. The impact of concomitant rhinitis on asthma-related quality of life and asthma control. Allergy. 2010;65:1290–1297. doi:10.1111/j.1398-9995.2010.02365.x
   PubMed Web of Science ®Google Scholar
• Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J. 2009;18:300–305. doi:10.4104/pcrj.2009.00037
   PubMedGoogle Scholar
• Steppuhn H, Langen U, Scheidt-Nave C, Keil T. Major comorbid conditions in asthma and association with asthma-related hospitalizations and emergency department admissions in adults: results from the German National Health Telephone Interview Survey (GEDA) 2010. BMC Pulm Med. 2013;13:46. doi:10.1186/1471-2466-13-46
   Web of Science ®Google Scholar
• Janson C, Lisspers K, Stallberg B, et al. Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR). Eur Respir J. 2018;52:pii: 1701927. doi:10.1183/13993003.01927-2017
   Web of Science ®Google Scholar
• Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113:925–931. doi:10.1016/j.jaci.2004.01.778
   PubMed Web of Science ®Google Scholar
• Skolnick HS, Conover-Walker MK, Koerner CB, Sampson HA, Burks W, Wood RA. The natural history of peanut allergy. J Allergy Clin Immunol. 2001;107:367–374. doi:10.1067/mai.2001.112129
   PubMed Web of Science ®Google Scholar
• Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002;109:419–425. doi:10.1067/mai.2002.121701
   PubMed Web of Science ®Google Scholar
• Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372:1049–1057. doi:10.1016/S0140-6736(08)61446-4
   PubMed Web of Science ®Google Scholar
• Boulet L-P, Boulay M-È. Asthma-related comorbidities. Expert Rev Respir Med. 2011;5:377–393. doi:10.1586/ers.11.34
   PubMed Web of Science ®Google Scholar
• Heck S, Al-Shobash S, Rapp D, et al. High probability of comorbidities in bronchial asthma in Germany. NPJ Prim Care Respir Med. 2017;27:28. doi:10.1038/s41533-017-0026-x
   PubMed Web of Science ®Google Scholar
• Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378:2486–2496. doi:10.1056/NEJMoa1804092
   PubMed Web of Science ®Google Scholar
• Rabe KF, Nair P, Brusselle G, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378:2475–2485. doi:10.1056/NEJMoa1804093
   PubMed Web of Science ®Google Scholar
• Marcus P, Arnold RJ, Ekins S, et al. A retrospective randomized study of asthma control in the US: results of the CHARIOT study. Curr Med Res Opin. 2008;24:3443–3452. doi:10.1185/03007990802557880
   PubMed Web of Science ®Google Scholar
• Boden SR, Burks AW. Anaphylaxis: a history with emphasis on food allergy. Immunol Rev. 2011;242:247–257. doi:10.1111/j.1600-065X.2011.01028.x
   PubMed Web of Science ®Google Scholar
• Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016;4:565–572. doi:10.1016/j.jaip.2016.04.012
   PubMed Web of Science ®Google Scholar
• Our Databases; 2020. Available from: https://opcrd.co.uk/our-database/. Accessed September 15, 2021.
   Google Scholar
• Wong MM, Keith PK. Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review. Allergy Asthma Clin Immunol. 2020;16:72. doi:10.1186/s13223-020-00461-x
   Web of Science ®Google Scholar